154 related articles for article (PubMed ID: 23930153)
1. Advancement of Imidazo[1,2-
Moraski GC; Markley LD; Cramer J; Hipskind PA; Boshoff H; Bailey M; Alling T; Ollinger J; Parish T; Miller MJ
ACS Med Chem Lett; 2013 Jul; 4(7):675-679. PubMed ID: 23930153
[TBL] [Abstract][Full Text] [Related]
2. Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.
Moraski GC; Markley LD; Hipskind PA; Boshoff H; Cho S; Franzblau SG; Miller MJ
ACS Med Chem Lett; 2011 Jun; 2(6):466-470. PubMed ID: 21691438
[TBL] [Abstract][Full Text] [Related]
3. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
[TBL] [Abstract][Full Text] [Related]
4. Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and "Anagrams" Generated Potent Antituberculosis Agents.
Moraski GC; Miller PA; Bailey MA; Ollinger J; Parish T; Boshoff HI; Cho S; Anderson JR; Mulugeta S; Franzblau SG; Miller MJ
ACS Infect Dis; 2015 Feb; 1(2):85-90. PubMed ID: 25984566
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
Tang J; Wang B; Wu T; Wan J; Tu Z; Njire M; Wan B; Franzblauc SG; Zhang T; Lu X; Ding K
ACS Med Chem Lett; 2015 Jul; 6(7):814-8. PubMed ID: 26191372
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
[TBL] [Abstract][Full Text] [Related]
8. Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.
Moraski GC; Markley LD; Chang M; Cho S; Franzblau SG; Hwang CH; Boshoff H; Miller MJ
Bioorg Med Chem; 2012 Apr; 20(7):2214-20. PubMed ID: 22391032
[TBL] [Abstract][Full Text] [Related]
9. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
[TBL] [Abstract][Full Text] [Related]
10. Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis.
Abdullahi M; Adeniji SE; Arthur DE; Haruna A
J Genet Eng Biotechnol; 2021 Jan; 19(1):12. PubMed ID: 33474593
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y
Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507
[TBL] [Abstract][Full Text] [Related]
12. Identification of
Wu Z; Lu Y; Li L; Zhao R; Wang B; Lv K; Liu M; You X
ACS Med Chem Lett; 2016 Dec; 7(12):1130-1133. PubMed ID: 27994751
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties.
Liu R; Marshall K; Ma R; Lien Thi Pham K; Shetye G; Liu Z; Cho S; Jeong H; Franzblau SG; Moraski GC; Miller MJ
Bioorg Chem; 2022 Nov; 128():106074. PubMed ID: 35987188
[TBL] [Abstract][Full Text] [Related]
14. [Determination of in vitro synergy by a checkerboard method when 3 core antimicrobial agents of the retreatment new scheme combined against MDR-MTB and XDR-MTB].
Zhang LL; Yang H; Xiao HP; Lu JM; Sha W; Zhang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):464-8. PubMed ID: 27289577
[TBL] [Abstract][Full Text] [Related]
15. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal effect of pyridine-2-thiol 1-oxide sodium salt and its complex with iron against resistant clinical isolates of Mycobacterium tuberculosis.
Campos DL; Machado I; Ribeiro CM; Gambino D; Pavan FR
J Antibiot (Tokyo); 2020 Feb; 73(2):120-124. PubMed ID: 31619772
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY
Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
[TBL] [Abstract][Full Text] [Related]
20. Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB.
Li D; Gao N; Zhu N; Lin Y; Li Y; Chen M; You X; Lu Y; Wan K; Jiang JD; Jiang W; Si S
Bioorg Med Chem Lett; 2015 Nov; 25(22):5178-81. PubMed ID: 26459210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
